Trauma Injury: Clinical Trials

7 trials for Trauma Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 1 not yet recruiting, 1 withdrawn. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Recruiting 2, Not yet recruiting 1, Withdrawn 1

Follow Trauma Injury: new trials by email Literature Review of Trauma Injury trials Research Report on Trauma Injury

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study
Tranexamic acid injection - Brain Injuries, Traumatic, Wounds and Injury
Phase 3Not yet recruitingDaniel Nishijima, MD, MAS20002026-10-012025-12-15
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Low Titer Group O Whole Blood (LTOWB), Placebo, Tranexamic Acid (TXA) - Hemorrhagic Shock, Trauma Injury
Phase 3RecruitingPhilip Spinella10002024-11-012026-09-17
Whole Blood in Trauma Patients With Hemorrhagic Shock
Transfusion of blood products - Trauma, Trauma Injury
Phase 3RecruitingFundacion Clinica Valle del Lili2202023-01-142025-02-27
Placebo Versus Oxandrolone Supplementation in Trauma
Oxandrolone, Placebo - Trauma Injury
Phase 3WithdrawnSunnybrook Health Sciences Centre2022-05-192023-08-14
Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs
Diclofenac Sodium 140 mg medicated plaster, Diclofenac epolamine (DIEP) 180mg medicated plaster, Flector, Placebo - Trauma Injury, Inflammation
Phase 3CompletedFidia Farmaceutici s.p.a.2142018-05-252023-10-02
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Cryoprecipitate, Red Blood Cells, Plasma - Trauma Injury
Phase 3CompletedBryan Cotton16042017-01-012025-01-14
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
Tranexamic Acid - Hemorrhagic Shock, Trauma Injury
Phase 3CompletedArrowhead Regional Medical Center2002015-03-012024-07-30

Narrower conditions

Accidental Injuries (7)  ·  Hemorrhage (2)  ·  Shock, Hemorrhagic (2)  ·  Wounds and Injuries (2)  ·  Brain Injuries (1)  ·  Brain Injuries, Traumatic (1)  ·  Inflammation (1)  ·  Multiple Trauma (1)

Broader conditions

Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Wounds and Injuries (5)  ·  Hemorrhage (2)  ·  Shock (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Craniocerebral Trauma (1)  ·  Nervous System Diseases (1)  ·  Trauma, Nervous System (1)

Interventions

Tranexamic Acid (3)  ·  Blood Transfusion (1)  ·  Diclofenac (1)  ·  Erythrocyte Count (1)  ·  Oxandrolone (1)  ·  Platelet Count (1)  ·  cryoprecipitate coagulum (1)  ·  diclofenac hydroxyethylpyrrolidine (1)

Sponsors

Arrowhead Regional Medical Center (1)  ·  Bryan Cotton (1)  ·  Daniel Nishijima, MD, MAS (1)  ·  Fidia Farmaceutici s.p.a. (1)  ·  Fundacion Clinica Valle del Lili (1)  ·  Philip Spinella (1)  ·  Sunnybrook Health Sciences Centre (1)

Countries

United States (2)  ·  Colombia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Alberto F Garcia, MD MSc (1)  ·  Bryan A Cotton, MD (1)  ·  Daniel K Nishijima, MD, MAS (1)  ·  Michael Neeki (1)  ·  Nathan Kuppermann, MD, MPH (1)  ·  Nicola Giordan (1)  ·  Philip C Spinella, MD (1)

Results publications

PMID 28611888, PMID 31271691, PMID 31299040, PMID 32278572, PMID 37824155, PMID 39898869, PMID 40087111